Zotefoams to announce preliminary results on 7th April

ZTF

Zotefoams PLC (LON:ZTF), a world leader in cellular materials technology, will announce preliminary results for the year ended 31 December 2019 on Tuesday 7 April 2020.

An analyst conference call will take place at 9.30am.  Would analysts interested in attending the presentation please contact [email protected].

In addition, Zotefoams is committed to ensuring that there are appropriate communication structures for all elements of its shareholder base so that its strategy, business model and performance are clearly understood. 

In order to access and engage with existing and potential shareholders efficiently, Zotefoams has adopted the Investor Meet Company communications platform.

Investor Meet Company is a digital platform that provides individual investors the same direct access to management as institutional investors around company announcements. Through live, interactive presentations, as part of the investor roadshow, all investors can now have the same opportunity for two-way engagement regardless of the number of shares they own or where they are located, so they can come to an informed decision about Zotefoams. 

Investors can sign up to Investor Meet Company for free at  https://www.investormeetcompany.com/register and click on add to meet Zotefoams. Investors who have already registered and added to meet the Company will be automatically invited.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:

Latest Company News

Barclays reports 12% profit growth, announces £500m share buyback

Barclays reported a 12% increase in third-quarter profit before tax to £2.3bn, with income rising 3% to £7.4bn and return on tangible equity improving to 11.7%. The bank announced a £500m share buyback, taking year-to-date shareholder distributions to £2.8bn, up 46% year-on-year, and reaffirmed its 2026 and 2028 financial targets.

RELX reports 7% underlying revenue growth and reaffirms full-year outlook

RELX reported 7% underlying revenue growth for the first nine months of 2026, led by Legal at 10%, Risk at 8% and Scientific, Technical & Medical at 6%. The group expects another year of strong underlying revenue and adjusted operating profit growth, supported by continued demand for AI-enabled analytics and decision tools.

Volta Finance generates €38m in interest income with 1.8x dividend cover

Volta Finance Limited generated €38 million in portfolio interest income during FY2026, supporting dividend cover of 1.8 times. The company maintained its quarterly dividend policy, with a projected portfolio yield of 12.8% and a diversified portfolio of 103 CLO positions across 46 managers.

Verici Dx secures Asahi Kasei Therapeutics order for phase 2 transplant trial

Verici Dx will provide blood-based biomarker testing, including its Pre-Transplant Risk Assessment assay, for a Phase 2 clinical trial evaluating pegrizeprument, an investigational immunosuppressive therapy designed to prevent acute rejection in solid organ transplant recipients.

Record AUM rises 7% to $130.3bn as net inflows reach $10.4bn

Record plc reported a 7% increase in assets under management to $130.3 billion in the three months to 30 September 2026, supported by $10.4 billion in net inflows, marking its fifth consecutive quarter of positive net flows.

Cora Gold confirms Eagle Eye shareholding transfer and gold stream restructuring to A2MP

Cora Gold says its largest shareholder plans to transfer its stake and gold stream rights to subsidiary A2MP Investments FZCO.

    Search